| Medical and Health Sciences | Lifetime | 481 | GB 53 | 99.98 |
| Rheumatology | Lifetime | 24 | GB 4 | 99.88 |
| Surgery | Lifetime | 547 | GB 41 | 99.50 |
| Anatomy | Lifetime | 37 | GB 4 | 98.63 |
| Nephrology | Lifetime | 73 | GB 3 | 99.49 |
| Clinical Pharmacology | Lifetime | 220 | GB 23 | 99.10 |
| Complementary and Alternative Medicine | Lifetime | 631 | GB 57 | 95.17 |
| Rehabilitation | Lifetime | 359 | GB 44 | 95.21 |
| Orthopedics and Sports Medicine | Lifetime | 595 | GB 55 | 94.17 |
| Rheumatology | 2021-2025 | 250 | GB 20 | 92.17 |
| Nephrology | 2021-2025 | 318 | GB 15 | 73.55 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 7 | GB 1 | 99.90 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 4 | GB 1 | 99.77 |
| Inflammatory mediators and NSAID effects | Lifetime | 19 | GB 3 | 99.71 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 5 | GB 2 | 99.64 |
| Case Reports on Hematomas | Lifetime | 4 | GB 1 | 99.63 |
| Medical and Biological Sciences | Lifetime | 48 | GB 5 | 98.57 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 108 | GB 15 | 99.47 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 61 | GB 6 | 99.04 |
| Spondyloarthritis Studies and Treatments | Lifetime | 77 | GB 12 | 99.03 |
| Urticaria and Related Conditions | Lifetime | 120 | GB 6 | 98.66 |
| Hip disorders and treatments | Lifetime | 157 | GB 14 | 98.64 |
| Alkaline Phosphatase Research Studies | Lifetime | 38 | GB 4 | 97.36 |
| Musculoskeletal pain and rehabilitation | Lifetime | 605 | GB 68 | 98.23 |
| Clinical practice guidelines implementation | Lifetime | 236 | GB 48 | 97.19 |
| Systemic Lupus Erythematosus Research | Lifetime | 673 | GB 71 | 98.07 |
| Bone and Joint Diseases | Lifetime | 336 | GB 31 | 97.26 |
| Knee injuries and reconstruction techniques | Lifetime | 443 | GB 22 | 97.91 |
| Lower Extremity Biomechanics and Pathologies | Lifetime | 371 | GB 22 | 97.64 |
| Shoulder Injury and Treatment | Lifetime | 816 | GB 45 | 97.60 |
| Total Knee Arthroplasty Outcomes | Lifetime | 885 | GB 74 | 97.40 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 496 | GB 59 | 96.04 |
| Dermatological and Skeletal Disorders | Lifetime | 258 | GB 28 | 95.20 |
| Tendon Structure and Treatment | Lifetime | 909 | GB 68 | 94.75 |
| Eosinophilic Disorders and Syndromes | Lifetime | 957 | GB 64 | 93.92 |
| Muscle and Compartmental Disorders | Lifetime | 630 | GB 45 | 89.70 |
| Delphi Technique in Research | Lifetime | 775 | GB 202 | 87.38 |
| Medicinal plant effects and applications | Lifetime | 366 | GB 4 | 86.00 |
| Intramuscular injections and effects | Lifetime | 499 | GB 40 | 74.18 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 365 | GB 15 | 92.70 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 140 | GB 3 | 86.18 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 969 | GB 69 | 87.10 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 296 | GB 6 | 82.12 |
| Musculoskeletal synovial abnormalities and treatments | 2021-2025 | 297 | GB 22 | 75.96 |
| Advanced Optical Network Technologies | 2021-2025 | 796 | GB 29 | 69.06 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 841 | GB 109 | 43.16 |
